Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Basta currently holds 81,571 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Basta has been a net seller of NTLA stock. They have purchased $0 and sold $278.0K worth of shares.
James Basta's most recent insider trade was on Mar 4, 2024, when they sold 2,297 shares at $32.99 per share.
James Basta serves as Executive at Intellia Therapeutics, Inc. (NTLA). They have executed 10 insider transactions totaling $278.0K over their tenure at the company.
James Basta holds the position of Executive at Intellia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
James Basta has shown a selling trading pattern, with $0 in total purchases and $278.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Basta was on Jan 3, 2024, when they sold $112.1K worth of NTLA shares. This transaction involved 3,805 shares at $29.46 per share.
James Basta currently owns 81,571 shares of Intellia Therapeutics, Inc. (NTLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Basta's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Basta has 10 Form 4 filings on record as an insider at Intellia Therapeutics, Inc..
Set alerts for James Basta and 40,000+ other insiders.